AD

Andrea Deutsch

Head Of Global PV Operations & Deputy QPPV at Valneva

Andrea Deutsch's work experience begins in 2001 as a CTA at the Medical University of Vienna. Andrea then worked as a CTA at the Veterinary University Vienna from 2005 to 2006. From 2009 to 2012, they were a University Assistant at the University of Vienna. In 2013, they held various roles, including being an Assistant to the Quality Manager at public Pharmacy and a University Lecturer at the University of Vienna. Andrea also worked as an Instructor at MERA Bildungsholding GmbH. In 2013, they joined Sanova Pharma GesmbH as a Pharmacovigilance Manager/Deputy QPPV. From 2014 to 2016, they served as the Corporate Drug Safety Officer at Octapharma. In 2016, they became the Manager of Pharmacovigilance at PharmaLex GmbH. Since 2017, they have been working at Valneva, initially as a Medical Information and Pharmacovigilance Expert, Deputy QPPV, followed by roles as Senior Pharmacovigilance Expert & Deputy QPPV, Manager PV Operations & Deputy QPPV, and currently as the Head of Global PV Operations & Deputy QPPV.

Andrea Deutsch holds a Master's degree in Pharmazieverwaltung und Pharmazierichtlinien und regulatorische Angelegenheiten, which they obtained from IMC Krems University of Applied Sciences between 2011 and 2013. Prior to that, they completed a Diplomstudium in Biochemie und Molekularbiologie at the University of Vienna from 2001 to 2008. Their education also includes a Diplom in Chemie from HTBLVA Rosensteingasse, which they earned from 1998 to 2000. Additionally, Andrea has achieved certifications such as certified Quality Manager & internal Quality Auditor from TÜV AUSTRIA in 2022 and Foundational ICH-Good Clinical Practice (GCP) E6 (R2) Training from ECCRT in 2020.

Links

Previous companies

Octapharma logo

Timeline

  • Head Of Global PV Operations & Deputy QPPV

    May, 2023 - present

  • Manager PV Operations & Deputy QPPV

    July, 2021

  • Senior Pharmacovigilance Expert & Deputy QPPV

    January, 2019

  • Medical Information And Pharmacovigilance Expert, Deputy QPPV

    September, 2017